Obermatt

NovaBridge Biosciences

NMQ:NBP · US44975P1030
BiotechnologySmall

360° View

no current rank
Price/Sales
Price/Earnings17
Price/Book67
Dividend Yield
Revenue Growth1
Profit Growth92
Capital Growth28
TSR 52w6
Leverage70
Liquidity37
Refinancing13
Combined
Analyst Opinions100
Pro Holdings15
Opinion Changes50
Market Pulse6

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2016
Employees92
ISINUS44975P1030
Last UpdateApr 2, 2026
Index & Theme
ImmunologyOphthalmologyOncologyBiopharmaBiotechnologyManufacturing

Description

NovaBridge Biosciences and its subsidiaries are principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology, and immuno-inflammation diseases in the People’s Republic of China (the ‘PRC’), and other c…

Similar Stocks

The companies this stock is ranked against.

Compare NovaBridge Biosciences with its peers
Surrozen
NAQ:SRZN
33
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kodiak Sciences
NMQ:KOD
82
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Cabaletta Bio
NSQ:CABA
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Corvus Pharmaceuticals
NMQ:CRVS
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Replimune Group
NSQ:REPL
1
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zymeworks
NSQ:ZYME
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →